Investigation and development unit focused on the generation of new technologies in regenerative medicine based on advanced therapy (cell therapy, gene therapy and tissue engineering).

Product scaling
of advanced therapy

Preclinical models
for advanced therapy

Generation of spheroids for immunomodulation studies.

Extracellular vesicles for biotechnological applications

Apoptotic bodies and immunomodulation

Bioengineering
of the skin tissue

Biological scaffolds for skin regeneration

Design, modeling and 3D printing of skeletal structures

Bioengineering
of bone tissue

Mesenchymal stromal cell encapsulation
for advanced therapy

Model generation
3D hematopoiesis

Design of instruments and technologies for biomedical investigation.

Factor extended release systems
and antibiotics for tissue engineering

Scaffolds for skin regeneration with new biomaterials

Adoptive antiviral therapy

Tumor infiltrating lymphocyte therapy

Design of devices for T-lymphocyte expansion

CAR-T cell engineering

Advanced therapies
for SARS-CoV2

Effector capacity developed by "CAR T-cells" in the expansion process.

Enhanced immunotherapy based on gene engineering

CRISPR-Cas9-based disease models